Who Owns AmerisourceBergen?
AmerisourceBergen is owned by Cencora Inc., a publicly traded American pharmaceutical distribution company listed on the NYSE (COR). Cencora operates AmerisourceBergen as their core pharmaceutical distribution brand following the company's name change from AmerisourceBergen to Cencora in 2023.
Parent Company
Cencora Inc.
Founded
2001
Status
Publicly Traded
Headquarters
Conshohocken, Pennsylvania, USA
Who Owns AmerisourceBergen?
- Parent Company: Cencora Inc.
- Ownership Type: Brand division
- Company Type: Publicly Traded
- Stock Ticker: NYSE: COR
| Brand | Parent Company | Ownership Type |
|---|---|---|
| AmerisourceBergen | Cencora Inc. | Brand division |
History of AmerisourceBergen
- Founded: 2001
- Founders: Formed through merger of AmeriSource and Bergen Brunswig
AmerisourceBergen was founded in 2001 through the merger of AmeriSource Health Corporation and Bergen Brunswig Corporation, creating one of the largest pharmaceutical distribution companies in the United States. Both predecessor companies had long histories in pharmaceutical distribution, with AmeriSource tracing its roots to 1977 and Bergen Brunswig dating back to 1907. The merger combined their extensive distribution networks, customer relationships, and operational expertise, creating a pharmaceutical distribution powerhouse that could leverage the strengths and market positions of both legacy companies while achieving significant operational synergies and cost efficiencies.
Throughout the 2000s and 2010s, AmerisourceBergen expanded through strategic acquisitions and organic growth, building capabilities in specialty pharmaceuticals, manufacturer services, and international markets. The company formed key partnerships, including a significant relationship with Walgreens that created one of the largest pharmaceutical distribution and retail pharmacy collaborations in the industry. This partnership enhanced AmerisourceBergen's market position and expanded its reach into community pharmacy settings, demonstrating the company's ability to create strategic alliances that could strengthen its competitive position and expand its service offerings.
The company invested heavily in technology and logistics infrastructure to improve efficiency and service quality across its distribution network. AmerisourceBergen developed sophisticated inventory management systems, cold chain capabilities for specialty pharmaceuticals, and data analytics services to help both manufacturers and healthcare providers optimize their pharmaceutical supply chain operations. This investment in technology and infrastructure demonstrated AmerisourceBergen's commitment to innovation and its ability to leverage advanced logistics and information systems to maintain competitive advantages in the rapidly evolving pharmaceutical distribution industry.
In August 2023, AmerisourceBergen Corporation officially changed its name to Cencora Inc. to better reflect its evolution beyond traditional pharmaceutical distribution into broader healthcare services. The rebranding represented the company's transformation into a more diversified healthcare services organization with expanded capabilities in specialty pharmacy, manufacturer services, and international markets. The AmerisourceBergen brand continues to represent the company's core pharmaceutical distribution operations, maintaining its legacy and market recognition while operating within the broader Cencora corporate structure and strategic framework.
About Cencora Inc.
What does Cencora do?
Cencora distributes pharmaceutical products, including brand-name drugs, generic drugs, and specialty medications, to pharmacies, hospitals, physician offices, and other healthcare providers across the United States and internationally. The company also provides manufacturer services, patient support programs, specialty logistics, and veterinary pharmaceutical distribution through its subsidiaries.
Is Cencora publicly traded?
Yes, Cencora, Inc. trades on the New York Stock Exchange under ticker symbol COR. The company has no controlling shareholder, though Walgreens Boots Alliance holds approximately 15% of shares as the largest single investor.
What is Cencora's annual revenue?
In fiscal year 2024 (ended September 30, 2024), Cencora reported revenue of $294.0 billion, a 12.1% increase from the prior fiscal year. The company is one of the largest companies in the United States by revenue.
Why did AmerisourceBergen change its name to Cencora?
AmerisourceBergen changed its name to Cencora in August 2023 to reflect its evolution from a primarily domestic pharmaceutical distributor into a global healthcare solutions organization. The rebranding followed the 2021 acquisition of Alliance Healthcare, which significantly expanded the company's international operations, and was intended to signal the company's broader capabilities beyond traditional drug distribution.
Who is Cencora's CEO?
Robert P. Mauch became President and CEO of Cencora on October 1, 2024, succeeding Steven H. Collis, who had served as CEO since 2011. Collis transitioned to the role of Executive Chairman.
What is Cencora's role in the opioid settlement?
Cencora, along with McKesson and Cardinal Health, reached a $21 billion settlement with U.S. states and local governments in 2022 to resolve claims that the three distributors failed to adequately monitor suspicious opioid orders. Cencora's share of the settlement is approximately $6.1 billion, to be paid over 18 years.
- Founded: 2001
- Headquarters: Conshohocken, Pennsylvania, USA
- Company Type: Publicly Traded
- Stock: NYSE: COR
Where Is AmerisourceBergen Made / Based?
- Headquarters: Conshohocken, Pennsylvania, USA
- Manufacturing / Operations: United States
Brands Owned by Cencora Inc.
- GoodRx - American healthcare technology platform providing prescription drug price compar...
- Lash Group - Patient support services company providing pharmaceutical patient assistance pro...
- MWI Animal Health - Animal health pharmaceutical and supply distributor providing veterinary medicat...
- OneOncology - Physician-led community oncology platform providing practice management, clinica...
- Retina Consultants of America - Leading retina specialist management services organization providing practice ma...
- World Courier - Global specialty logistics and transportation company specializing in time-criti...
- Xcenda - Strategic consulting and market access company providing commercialization suppo...
AmerisourceBergen Ownership: Pros & Cons
Advantages
- +Market leadership position in pharmaceutical distribution
- +Critical role in healthcare supply chain providing stability
- +Strong relationships with pharmaceutical manufacturers and healthcare providers
- +Extensive distribution network across the United States
- +Established reputation and brand recognition in healthcare industry
Considerations
- -Regulatory scrutiny over drug pricing and distribution practices
- -Complex healthcare regulations affecting operations
- -Competition from other large distributors and technology companies
- -Pressure on pharmaceutical margins and pricing transparency
- -Balance between growth and regulatory compliance
Frequently Asked Questions About AmerisourceBergen
Where to Buy
Disclosure: We may earn commission from purchases
AmerisourceBergen on AmazonCompetitors to AmerisourceBergen
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Cardinal Health | USA | 2010 | Mass Market | North America | All Genders | |
| Piramal Pharma | India | 2007 | Mass Market | Global | Male |
Learn More About Competitors
Cardinal Health Specialty Pharmacy
Owned by Cardinal Health
Specialty pharmaceutical distribution and services provider serving specialty pharmacies, hospitals, and healthcare providers with complex medications owned by Cardinal Health.
Piramal Pharma Solutions
Owned by Piramal Pharma Limited
Global contract development and manufacturing organization providing integrated CDMO services across the drug lifecycle for pharmaceutical companies.
Competitive Analysis
Market Positioning: AmerisourceBergen competes with 2 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Cencora Inc. Stock Information
Jobs at Cencora Inc.
Latest News About AmerisourceBergen
Related Articles About AmerisourceBergen
View more articles
Monthly M&A Roundup: February 2026 Brand Ownership Changes
From Keurig Dr Pepper's planned split to the Netflix-WBD saga, here is every major brand ownership change and deal in February 2026.
The Most Acquired Categories: Tech vs CPG vs Pharma
Which industries see the most brand acquisitions? We compared technology, consumer goods, and pharmaceuticals to find out where the most M&A activity happens and why.
The Truth About 'Made in America' Brand Claims
Many brands market themselves as American-made. But what does that actually mean when the parent company is foreign, the parts come from overseas, and 'assembled in USA' is not the same as 'made in USA'?
People Also Searched
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.
Activase
Prescription thrombolytic medication for treating acute myocardial infarction and stroke, manufactured and marketed by Roche.
Acuvue
American brand of contact lenses and vision care products specializing in daily disposable and extended wear contact lenses, manufactured and marketed by Johnson & Johnson.
Adcetris
Prescription antibody-drug conjugate for treating Hodgkin lymphoma and other CD30-positive lymphomas, manufactured and marketed by Takeda Pharmaceutical Company.